secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2026-08-27T20:05:28+00:00
Accession:  0001193125-26-371260
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics receives Nasdaq delisting notice for bid price below $1.00
----------------------------------------------------------------------------

- Received delisting notice from Nasdaq on Aug 21, 2026 for bid price below $1.00 for 30 consecutive trading days.
- Has 180 days, until Feb 17, 2027, to regain compliance with minimum bid price rule.
- Must achieve closing bid of at least $1.00 for 10 consecutive business days to cure.
- May be eligible for additional time if meeting other Capital Market listing standards, but no assurance given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526371260/0001193125-26-371260-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526371260/d154403d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-371260

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer